Core Viewpoint - The document provides a supplementary legal opinion regarding Nanjing Maolai Optical Technology Co., Ltd.'s issuance of convertible bonds to unspecified objects, addressing inquiries from the Shanghai Stock Exchange and confirming the legality and compliance of the issuance process [2][3]. Group 1: Issuance Details - The issuance involves a project for "ultra-precision optical production processing" which aims to establish mass production capabilities for ultra-precision optical components and lenses [3][10]. - The "ultra-precision optical technology research center project" will create high-standard laboratories focusing on various technical research and improvements [3][10]. - Environmental impact assessments (EIA) for the projects are currently being processed [3][9]. Group 2: Environmental Compliance - The projects require the preparation of an Environmental Impact Report, as they fall under specific categories that necessitate such evaluations according to national regulations [9][10]. - The company has submitted the EIA report to the relevant authorities and is currently making adjustments based on preliminary review comments, with an expected approval by the end of July 2025 [9][10]. Group 3: Financial and Operational Impact - The main products from the "ultra-precision optical production processing" project include precision optical devices, high-end optical lenses, and advanced optical systems [10][11]. - The projects align with the company's existing business operations, which involve the research, design, manufacturing, and sales of precision optical components [11][19]. Group 4: Shareholder Participation - Major shareholders, directors, and senior management have provided commitments regarding their participation in the convertible bond issuance and have confirmed no plans for share reduction in the six months preceding or following the issuance [12][19]. - The company has not issued convertible bonds since its initial public offering [12][19]. Group 5: Legal Compliance - The company and its subsidiaries have not faced administrative penalties or major legal violations during the reporting period, confirming compliance with relevant legal standards [19][26]. - The issuance of convertible bonds meets the requirements set forth in the applicable securities regulations, ensuring no legal obstacles to the financing process [19][26].

青岛华航环境科技有限责任公司，成立于2014年，位于青岛市，是一家以从事仪器仪表制造业为主的企 业。企业注册资本2215万人民币。通过天眼查大数据分析，青岛华航环境科技有限责任公司共对外投资 了1家企业，参与招投标项目151次，财产线索方面有商标信息3条，专利信息26条，此外企业还拥有行 政许可6个。 上海雷探科技有限公司，成立于2017年，位于上海市，是一家以从事科技推广和应用服务业为主的企 业。企业注册资本500万人民币。通过天眼查大数据分析，上海雷探科技有限公司参与招投标项目48 次，财产线索方面有商标信息3条，专利信息33条，此外企业还拥有行政许可2个。 来源：金融界 金融界2025年6月20日消息，国家知识产权局信息显示，中国长江三峡集团有限公司、上海勘测设计研 究院有限公司、青岛华航环境科技有限责任公司、上海雷探科技有限公司取得一项名为"一种海上风能 资源探测装置"的专利，授权公告号CN115523384B，申请日期为2022年10月。 天眼查资料显示，中国长江三峡集团有限公司，成立于1993年，位于武汉市，是一家以从事电力、热力 生产和供应业为主的企业。企业注册资本21150000万人民币。通过 ...

导读： 2024年国产仪器行业营收分化，头部企业如安图生物逆势增长，高分红拉大老板收入差距，出海战略成关键驱动力，环境监测与工业过程领域面临挑战， 成本压力加剧。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 在宏观经济增速换挡与产业升级并行的2024年，国产仪器行业整体营收呈现显著分化特征： 头部企业通过战略调整实现逆势增长，部分领域 则因市场收缩与成本压力陷入困境。 在此背景下，仪器信息网聚焦14家代表性企业，通过分析其财务数据，从企业领导者收入情况入手，深入 透视行业发展与企业治理的共性。 备 注 ： 收 入 = 薪 酬 + 分 红 ； 薪 酬 指 报 告 期 内 从 公 司 获 得 的 税 前 薪 酬 ； 分 红 指 派 发 的 现 金 红 利 。 国内上市仪器公司老板们的收入主要由报告期内从公司获得的税前薪酬（基础薪酬）以及向股东派发的现金红利两部分构成。本次统计的14家 企业老板收入，相比去年，收入极差进一步拉大。 高收入主要是由于高分红。 安图生物董事长苗拥军是今年唯一收入破亿的老板，且已连续两年达到这一水平（去年收入1.3 ...

Group 1: Current Business Operations - The company has developed a product system covering intelligent water and heat metering, with nearly a thousand specifications, widely used in urban water supply, centralized heating, and fire safety [3] - Main products include ultrasonic water meters, ultrasonic flow meters, intelligent fire hydrants, ultrasonic heat meters, and intelligent flow control valves [3] Group 2: Future Development Plans - The company operates three intelligent manufacturing plants, with a modern production line in the 38-acre Xiyan Road plant and a large-caliber flow calibration capability in the 92-acre Hori Mountain plant [4] - An 80-acre plant is under construction, which will fully integrate digital production lines, enhancing the company's industrial layout in ultrasonic metering [4] - Management is confident in the ultrasonic water meter market, with over 10 years of application cases and increasing customer recognition [4] Group 3: Market Expansion Strategies - The company has focused on ultrasonic fluid measurement technology since its inception, with initial products for heating measurement [5] - National policies support the ongoing reform of heating measurement, ensuring stable development for ultrasonic heat meters [5] - The company is actively expanding into overseas markets, having obtained EU MID factory and product certifications, and participating in international exhibitions [6] - Although the overseas market development has a longer sales cycle due to customization and strict technical requirements, initial results are promising [6]

Core Viewpoint - The report outlines the differentiated dividend distribution plan of Youlide Technology (China) Co., Ltd., confirming compliance with relevant laws and regulations, and indicating that the plan does not harm the interests of the company and its shareholders [5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is due to the company's decision to adjust the total cash dividend amount for the 2024 fiscal year, as announced on May 17, 2025 [1]. - The company has completed the registration of an additional 499,051 shares, increasing the total share capital from 111,281,997 shares to 111,781,048 shares [1]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of 10.00 yuan (including tax) for every 10 shares held, resulting in a total cash dividend distribution of 111,036,148 yuan (including tax) [2]. - The actual number of shares participating in the profit distribution is 111,036,148 shares after excluding 744,900 shares held in the repurchase account [2]. Group 3: Calculation Basis for Dividend Distribution - The reference price for ex-dividend trading is calculated using the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [3]. - With a closing price of 34.20 yuan on May 21, 2025, the calculated cash dividend per share is approximately 1.0 yuan, resulting in an ex-dividend reference price of 33.20 yuan per share [3][4]. - The impact of the differentiated dividend on the ex-dividend reference price is negligible, remaining below 1% [4]. Group 4: Sponsor Institution's Review Opinion - The sponsor institution, Changcheng Securities, confirms that the differentiated dividend distribution complies with the Company Law, Securities Law, and other relevant regulations, ensuring no harm to the interests of the company and its shareholders [5].

《跨国公司在中国：投资未来共赢发展再起航》在山东青岛发布 中新网青岛6月19日电 (胡耀杰 张孝鹏)《跨国公司在中国：投资未来共赢发展再起航》研究报告(简 称"报告")19日在第六届跨国公司领导人青岛峰会开幕式上发布。报告指出，依托中国超大规模人口基 数以及消费升级趋势，跨国公司在华市场空间不断拓展，营业收入实现稳定增长。 6月19日，《跨国公司在中国：投资未来共赢发展再起航》研究报告在青岛发布。张孝鹏 摄 编辑：徐世明 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 报告称，跨国公司促进中国加快制度型开放步伐，参与自贸试验区制度创新的场景试验，享受到更加便 利、开放的投资环境。数据显示，2024年，中国22个自贸试验区实际使用外资达282.5亿美元。 报告指出，跨国公司享受中国市场规模持续增长的红利，在华投资回报率处于较高水平。中国国家统计 局数据显示，2019年至2024年，全国规模以上外商投资工业企业营业收入从23. ...

导读： 根据2024年国内44家上市仪器企业人员变动数据显示：迈瑞医疗、纳微科技等企业扩招并加大研发投入，而禾信仪器、皖仪科技等则因营收压力裁员。同 时研发人员变化反映企业技术创新策略，行业整体呈现分化趋势。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 研发人员的变化更加直观地反映出企业在技术创新上的重视程度。迈瑞医疗不仅员工总数领先，其研发团队规模也达5259人，占比近25%， 同比增长18.85%，展现出其持续深化产品创新和技术升级的战略定力。纳微科技在研发端同样表现亮眼，研发人员数量同比增长37.14%， 研发投入同比增加25.84%，主要系公司持续加大产品的研发投入、加强高端技术人才引进、优化人员结构引起，以支撑公司在高精度、高性 能 、 高 质 量 微 球 材 料 研 发 和 生 产 领 域 的 技 术 延 展 。 普 源 精 电 的 研 发 投 入 从 2023 年 的 1.42 亿 元 增 长 至 2024 年 的 2.06 亿 元 ， 同 比 提 升 45.07%，研发人员增幅达到44.86%，反映出其在产品迭代与电子测 ...

导读： 2024年国产仪器行业营收分化，头部企业如安图生物逆势增长，高分红拉大老板收入差距，出海战略成关键驱动力，环境监 测与工业过程领域面临挑战，成本压力加剧。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 在宏观经济增速换挡与产业升级并行的 2024 年，国产仪器行业整体营收呈现显著分化特征： 头部企业通过战略调整 实现逆势增长，部分领域则因市场收缩与成本压力陷入困境。 在此背景下，仪器信息网聚焦 15 家代表性企业，通过 分析其财务数据，从企业领导者收入情况入手，深入透视行业发展与企业治理的共性。 | | | | | | 2024年15家国产仪器老板收入表 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | 单位: 万元 | | 排名 | 企业名称 | 姓名 | 电影 | 职位 | 2024收入 (新酬+分红) | 2024 新酬 | 2024 स्त्रहा | 2023收 入排名 | 收入 涨幅 | ...

导读： 本文依据52家国内上市仪器公司披露的员工数量、营业收入、净利润等详实数据，精心编制2024年度国内上市仪器公司人均营收和人均净利榜单，为行业 发展提供深度洞察与参考。 | 41 | 同位红外 | 33 | 40 / 139 | 3, IUU | | --- | --- | --- | --- | --- | | 42 | 易瑞生物 | 52 | 22,425 | 480 | | 43 | 新芝生物 | 50 | 16,809 | 323 | | 44 | 中科美菱 | 49 | 29,577 | 586 | | 45 | 天瑞仪器 | 49 | 85,112 | 1,655 | | 46 | 蓝盾光电 | 46 | 60,943 | 1,225 | | 47 | 禾信仪器 | 42 | 20,251 | 276 | | 48 | 泰林生物 | 41 | 34,900 | 797 | | 49 | 先河环保 | 41 | 95,251 | 2,326 | | 50 | 多浦乐 | 415 | 16,200 | 408 | | રા | 南华仪器 | 35 | 12,432 | 406 | | 52 | ...

Core Viewpoint - The article emphasizes the challenges faced in domestic substitution of scientific instruments in China, including information fragmentation, high verification costs, and risk aversion among decision-makers. It highlights the services provided by the Instrument Information Network to assist users in efficiently and accurately selecting domestic instruments [1][2]. Group 1: Challenges in Domestic Substitution - The lack of reliable data and case studies raises doubts about the performance stability, long-term reliability, precision consistency, and application adaptability of domestic instruments compared to imported ones [3]. - High verification costs deter users from switching to domestic instruments, as the process involves significant investment, reconfiguration of experimental processes, and potential certification risks [3]. - Decision-makers often exhibit a risk-averse mentality, preferring well-known imported brands to avoid accountability in case of issues, which complicates the adoption of new domestic solutions [3]. Group 2: Solutions Offered by Instrument Information Network - The Instrument Information Network has created a comprehensive database of successful domestic instrument substitution cases, technical white papers, performance benchmarks, and user evaluations to provide critical information [4]. - A "Domestic Instrument Selection Database" has been launched, featuring 49,374 domestic scientific instruments across 295 categories, addressing the needs of various laboratory sectors [5]. - The network offers free trial opportunities for specific domestic instruments, facilitating user experience before purchase [7]. Group 3: Events and Community Engagement - The fourth Domestic Good Instruments Trial Offline Matching Conference was successfully held, featuring the release of the "Domestic Good Instruments Manual" and discussions on the development of domestic instruments [8]. - The network has engaged with nearly 100 user units and participated in around 300 vendor interactions, helping users connect with manufacturers for efficient procurement [17]. Group 4: Expert Consultation and Support - A team of experienced consultants provides one-on-one in-depth selection consulting services, tailored to specific application needs, budget constraints, and laboratory environments [10]. - The network acts as a connector, facilitating direct communication with key personnel from leading domestic manufacturers to address resource bottlenecks in major procurement projects [16]. Group 5: User-Centric Approach - The initiative "Domestic Good Instruments" aims to bridge the gap between users and reliable domestic products, enhancing the recognition and acceptance of domestic instruments [11]. - A compilation of 161 selected "Domestic Good Instruments" will be presented to government procurement departments and laboratories to promote independent procurement of domestic scientific instruments [13].